Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients.
Lauren A DalvinQiang ZhangRose A HamershockMichael ChangMichael D YuArman MashayekhiCarol L ShieldsPublished in: The British journal of ophthalmology (2019)
A nomogram using clinical or treatment risk factors can predict visual acuity outcome following plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma and is available online at https://fighteyecancer.com/nomograms/.
Keyphrases
- risk factors
- early stage
- end stage renal disease
- vascular endothelial growth factor
- coronary artery disease
- newly diagnosed
- locally advanced
- ejection fraction
- diabetic retinopathy
- radiation therapy
- radiation induced
- chronic kidney disease
- age related macular degeneration
- prognostic factors
- metastatic colorectal cancer
- healthcare
- magnetic resonance imaging
- replacement therapy
- smoking cessation